Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPIVACAINE vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPIVACAINE vs ROSUVASTATIN: Safety Overview

Metric ROPIVACAINE ROSUVASTATIN
Total FAERS Reports 2,967 36,332
Deaths Reported 150 1,536
Death Rate 5.1% 4.2%
Hospitalizations 921 11,195
Average Patient Age 50.3 yrs 66.1 yrs
% Female Patients 72.3% 54.9%
FDA Approval Date Apr 11, 2016 Apr 1, 2020
Manufacturer NorthStar Rx LLC Umedica Laboratories USA Inc.
Route EPIDURAL ORAL
Marketing Status Prescription Prescription